Neurim Can't Bar Rival Sleep Aid Drug Ahead of IP Trial
An appellate court in London has refused to block sales of a generic version of Neurim Pharmaceuticals' insomnia treatment ahead of patent infringement trial, ruling that the company will be adequately...To view the full article, register now.
Already a subscriber? Click here to view full article